Theoretical Issues Relevant to the Economic Evaluation of Health Technologies

Handbook of Health Economics

Volumn 2, Issue , 2011, Pages 433-469

  Meltzer, David O ^a   Smith, Peter C ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cost effectiveness analysis; Health technology assessment; Medical decision making; Methodology

Indexed keywords

EID: 83255186898     PISSN: 15740064     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53592-4.00007-4     Document Type: Chapter

References (53)

1. Ades A.E., et al. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Economics 2006, 15(4):373-381.
2. Arrow K., Lind R. Uncertainty and the evaluation of public investment decisions. American Economic Review 1970, 16(3):364-378.
3. Arrow K.J. A difficulty in the concept of social welfare. Journal of Political Economy 1950, 58(4):328-346.
4. Baker R., et al. Weighting and valuing quality-adjusted life-years using stated preference methods: Preliminary results from the Social Value of a QALY Project. Health Technology Assessment 2010, 14(27):1-162.
5. Basu A., Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. Journal of Health Economics 2005, 24(4):751-773.
6. Birch S., Gafni A. Cost-effectiveness analyses: Do current decision rules lead us where we want to be?. Journal of Health Economics 1992, 11:279-296.
7. Birch S., Gafni A. Changing the problem to fit the solution: Johannesson and Weinstein's (mis)application of economics to real world problems. Journal of Health Economics 1993, 12:469-476.
8. Bleichrodt H., et al. Equity weights in the allocation of health care: The rank-dependent QALY model. Journal of Health Economics 2004, 23(1):157-171.
9. Braithwaite R.S., et al. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?. Medical Care 2008, 46(4):349-356.
10. Brouwer W.B.F., et al. Welfarism vs. extra-welfarism. Journal of Health Economics 2008, 27(2):325-338.
11. Chan Y. Improving hospital cost accounting with activity-based costing. Health Care Management Review 1993, 18(1):71-77.
12. Chapman R.H., et al. When does quality-adjusting life-years matter in cost-effectiveness analysis?. Health Economics 2004, 13(5):429-436.
13. Claxton K. The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics 1999, 18(3):341-364.
14. Claxton K., Posnett J. An economic approach to clinical trial design and research priority-setting. Health Economics 1996, 5(6):513-524.
15. Claxton K., Walker S., Palmer S., Sculpher M. Appropriate perspectives for health care decisions 2010, Centre for Health Economics, York, Research Paper RP54.
16. Claxton K., et al. Discounting and decision making in the economic evaluation of health-care technologies. Health Economics 2011, 20(1):2-15.
17. Cropper M.L., Portney P.R. Discounting and the evaluation of lifesaving programs. Journal of Risk and Uncertainty 1990, 3(4):369-379.
18. Culyer A.J. The bogus conflict between efficiency and vertical equity. Health Economics 2006, 15(11):1155-1158.
19. Dolan P., et al. QALY maximisation and people's preferences: A methodological review of the literature. Health Economics 2005, 14(2):197-208.
20. Drummond M., et al. Methods for the economic evaluation of health care programmes 2005, Oxford University Press, Oxford. 3rd ed.
21. Eddy D., et al. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Annals of Internal Medicine 2005, 143:251-264.
22. Garber A.M., Phelps C.E. Economic foundations of cost-effectiveness analysis. Journal of Health Economics 1997, 16(1):1-31.
23. Cost-effectiveness in health and medicine 1996, Oxford University Press, Oxford. M. Gold (Ed.).
24. Gravelle H., Smith D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Economics 2001, 10(7):587-599.
25. Gravelle H., et al. Discounting in economic evaluations: Stepping forward towards optimal decision rules. Health Economics 2007, 16(3):307-317.
26. Griffin S., Claxton K. Analyzing uncertainty in cost-effectiveness for decision-making. The Oxford handbook of health economics 2011, Oxford University Press, Oxford. S. Glied, P. Smith (Eds.).
27. Griffin S.C., et al. Dangerous omissions: The consequences of ignoring decision uncertainty. Health Economics 2010, 20(2):212-224.
28. Johannesson M., Weinstein M.C. On the decision rules of cost-effectiveness analysis. Journal of Health Economics 1993, 12(4):459-467.
29. Jönsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. European Journal of Health Economics 2009, 10:357-359.
30. Keeler E.B., Cretin S. Discounting of life-saving and other nonmonetary effects. Management Science 1983, 29(3):300-306.
31. Lancsar, E., et al. (2011). Deriving distributional weights for QALYs through discrete choice experiments. Journal of Health Economics. In press, Accepted Manuscript.
32. Lewis B., et al. Intention-to-treat analysis and the goals of clinical trials. Clinical Pharmocology 1995, 57:6-15.
33. Lipscomb J., et al. Time preference. Cost-effectivness in health and medicine 1996, Oxford University Press, Oxford. M. Gold, J. Siegel, L. Russell, M. Weinstein (Eds.).
34. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. Journal of Health Economics 1997, 16(1):33-64.
35. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis: Implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. Journal of Health Economics 2001, 20(1):109-129.
36. Meltzer D. Economic approaches to valuing global health research. Disease control priorities in developing countries 2006, Oxford University Press, Oxford. 2nd ed. D. Jamison (Ed.).
37. Meltzer D., et al. Effects of self-selection on medical cost-effectiveness analysis: Impact in intensive therapy for type 2 diabetes mellitus among the elderly. Medical Decision Making 2002, 22(6):535.
38. Meltzer, D., et al. (2011). Minimal modeling approaches to value of information analysis for health research. Medical Decision Making. Forthcoming.
39. Mogyorosy, Z. & Smith, P. (2005). The main methodological issues in costing health care services: A literature review. Research Paper RP7. York, Centre for Health Economics.
40. Neumann P. Costing and perspective in published cost-effectiveness analysis. Medical Care 2009, 47:S28-S32.
41. Neumann P., et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology 1999, 52(6):1138.
42. Nord E. Discounting future health benefits: The poverty of consistency arguments. Health Economics 2011, 20(1):16-26.
43. Palmer S., Smith P. Incorporating option values into the economic evaluation of health care technologies. Journal of Health Economics 2000, 19(5):755-766.
44. Phelps C.E., Mushlin A.I. On the (near) equivalence of cost-effectiveness and cost-benefit analysis. International Journal of Technology Assesment in Health Care 1991, 7(1):12-21.
45. Pratt J.W., et al. Introduction to statistical decision theory 1965, McGraw-Hill, New York.
46. Raiffa H., Schlaifer R. Applied statistical decision theory 1961, Harvard Business School, Colonial Press.
47. Smith P. User charges and priority setting in health care: Balancing equity and efficiency. Journal of Health Economics 2005, 24:1018-1029.
48. Smith P., Street A. On the uses of routine patient reported health outcome data 2011, Centre for Health Economics, York, Research Paper.
49. Stinnett A.A., Paltiel A.D. Mathematical programming for the efficient allocation of health care resources. Journal of Health Economics 1995, 15:641-653.
50. Torrance G. Measurement of health state utilities for economic appraisal: A review. Journal of Health Economics 1986, 5(1):1-30.
51. Weinstein M., Zeckhauser R. Critical ratios and efficient allocation. Journal of Public Economics 1973, 2(2):145-157.
52. Weinstein M.C., Manning W.G. Theoretical issues in cost-effectiveness analysis. Journal of Health Economics 1997, 16(1):121-128.
53. Williams A. Intergenerational equity: An exploration of the 'fair innings' argument. Health Economics 1997, 6(2):117-132.